Byetta and Pancreatitis necrotising - a phase IV clinical study of FDA data
Summary:
Pancreatitis necrotising is found among people who take Byetta, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Byetta and have Pancreatitis necrotising. It is created by eHealthMe based on reports of 60,144 people who have side effects when taking Byetta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60,144 people reported to have side effects when taking Byetta.
Among them, 112 people (0.19%) have Pancreatitis necrotising.
What is Byetta?
Byetta has active ingredients of exenatide synthetic. It is often used in diabetes. eHealthMe is studying from 60,540 Byetta users for its effectiveness, alternative drugs and more.
What is Pancreatitis necrotising?
Pancreatitis necrotising (inflammation of the pancreas cause death of tissue in pancreas) is found to be associated with 735 drugs and 348 conditions by eHealthMe.
Number of Byetta and Pancreatitis necrotising reports submitted per year:
Time on Byetta when people have Pancreatitis necrotising *:
Gender of people who have Pancreatitis necrotising when taking Byetta*:
Age of people who have Pancreatitis necrotising when taking Byetta *:
Common drugs people take besides Byetta *:
Common side effects people have besides Pancreatitis necrotising *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Byetta and have Pancreatitis necrotising?
Check whether Pancreatitis necrotising is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Pancreatitis necrotising and when was it recovered:
Expand to all the drugs that have ingredients of exenatide synthetic:
Alternative drugs to, pros and cons of Byetta:
- Byetta (60,540 reports)
Common Byetta side effects:
- Weight decreased: 14,204 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 6,471 reports
- Indigestion: 5,127 reports
- Diarrhea: 3,362 reports
- Pancreatitis (inflammation of pancreas): 3,275 reports
- Dizziness: 3,213 reports
- Drug ineffective: 2,546 reports
Browse all side effects of Byetta:
a b c d e f g h i j k l m n o p q r s t u v w x y zPancreatitis necrotising treatments and more:
- Pancreatitis necrotising (2,213 reports)
COVID vaccines that are related to Pancreatitis necrotising:
- Pancreatitis necrotising in Moderna COVID Vaccine
- Pancreatitis necrotising in Pfizer BioNTech Covid Vaccine
- Pancreatitis necrotising in Johnson and Johnson Covid Vaccine
Common drugs associated with Pancreatitis necrotising:
- Aspirin: 120 reports
- Byetta: 112 reports
- Ramipril: 112 reports
- Simvastatin: 110 reports
- Metformin: 104 reports
- Lisinopril: 101 reports
All the drugs that are associated with Pancreatitis necrotising:
- Pancreatitis necrotising (735 drugs)
Common conditions associated with Pancreatitis necrotising:
- High blood pressure: 219 reports
- Type 2 diabetes: 145 reports
All the conditions that are associated with Pancreatitis necrotising:
- Pancreatitis necrotising (348 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on exenatide synthetic (the active ingredients of Byetta) and Byetta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Protonix and Sunosi drug interaction - 3 seconds ago
- Zolpidem Tartrate and Splenic Injury - 8 seconds ago
- Voriconazole and Hypoglycemia - 9 seconds ago
- Zelnorm and Extrapyramidal Disorder - 10 seconds ago
- Armodafinil and Eczema Exacerbated - 16 seconds ago
- Eskalith Cr and Vasotec drug interaction - 29 seconds ago
- Epidiolex and Adverse Event - 31 seconds ago
- Omega-3 and Vitamin C drug interaction - 33 seconds ago
- Velcade and Small Intestinal Obstruction - 43 seconds ago
- Depression in Fenofibrate, how severe and when it was recovered? - 46 seconds ago